Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

• Status: Completed
• Trial end date: 2019-01-15
• Target enrollment: 0
• Participant gender: All

Summary

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kapiolani Medical Center For Women & Children

Criteria

Inclusion Criteria:

• direct bilirubin > 2 mg/dl x2 consecutive

• parenteral nutrition dependent, expected to continue for at least another 30 days from the first day

• patient must have utilized standard therapies to prevent the progression of liver disease

Exclusion Criteria:

• other primary cause of liver disease not parenteral nutrition-associated

• weight <3 kg

• infant or child enrolled in other clinical trial involving an investigational agent